ESMO 2019 Congress

Translating science into better cancer patient care​

Barcelona, Spain - 27 Sep - 01 Oct 2019

ESMO is delighted to announce that the ESMO 2019 annual Congress will take place in partnership with the European Association for Cancer Research (EACR) from 27 September to 1 October 2019, at the Fira Barcelona, Spain.

The ESMO Congress is the appointment in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology and translate science into better cancer patient care.

ESMO 2019 will be the global stage for excellence in translational research, presentation of practice-changing data and multidisiplinary discussions.

We invite you to save the date.

Congress Officers

  • 2019 ESMO and Congress President: Josep Tabernero, Barcelona, Spain
  • Scientific Co-Chair (ESMO): Jean-Yves Blay, Lyon, France
  • Scientific Co-Chair (EACR): Anton Berns, Amsterdam, Netherlands
  • Educational Chair: Andrés Cervantes, Valencia, Spain
  • Congress Press Officer: Pilar Garrido, Madrid Spain

ESMO 2019 Scientific Committee Track Chairs

Basic science: Caroline Dive, Manchester, UK
Breast cancer, early stage: Angelo Di Leo, Prato, Italy
Breast cancer, metastatic: Rebecca Dent, Singapore
CNS tumours: Martin van den Bent, Rotterdam, Netherlands
Developmental therapeutics: Emiliano Calvo, Madrid, Spain
Gastrointestinal tumours, colorectal: Claus-Henning Koehne, Oldenburg, Germany
Gastrointestinal tumours, non-colorectal: Ian Chau, Sutton, UK
Genitourinary tumours, prostate: Johann de Bono, Sutton, UK
Genitourinary tumours, non-prostate: Laurence Albiges, Villejuif, France
Gynaecological cancers: Ana Oaknin, Barcelona, Spain
Haematological malignancies: Michele Ghielmini, Bellinzona, Switzerland
Head and neck cancer: Lisa Licitra, Milan, Italy
Immunotherapy of cancer: Aurélien Marabelle, Villejuif, France
Melanoma and other skin tumours: Piotr Rutkowski, Warsaw, Poland
NETs and endocrine tumours: George Pentheroudakis, Ioannina, Greece
Non-metastatic NSCLC and other thoracic malignancies: Paul Van Schil, Edegem, Belgium
NSCLC, metastatic: Tony S.K. Mok, Hong Kong, China
Public policy: Elisabeth de Vries, Groningen, Netherlands
Sarcoma: Sebastian Bauer, Essen, Germany
Supportive and palliative care: Florian Scotté, Paris, France
Translational Research:  Sabine Linn, Amsterdam, Netherlands (ESMO) and Alberto Bardelli, Turin, Italy (EACR)

Press Release

13 June 2016: ESMO 2019 Annual Congress to be held in Barcelona